4.5 Article

Self-renewal mechanisms in neural cancer stem cells

Journal

FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 16, Issue -, Pages 598-607

Publisher

FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/3708

Keywords

Stem cell; cancer stem cell; cancer; self-renewal; proliferation; signaling pathway; Review

Funding

  1. EU [231032]

Ask authors/readers for more resources

The view that there are cancer-initiating stem cells has led to a concerted effort to understand the nature of these cells. As in many tissues, rare populations of cancer stem cells have been characterized in neural cancers, including glioblastoma, medulloblastoma and epyndymoma. The ability of stem cells to undergo both symmetric (self-renewal) and asymmetric (division to produce a more differentiated cell) cell division is what defines them as stem cells. Understanding the molecular genetic mechanisms governing the self-renewal and proliferation of these cells will be important in developing novel more effective strategies which will perhaps lead to better treatments for many cancers, including some of the most difficult to treat, such as the most common and aggressive brain cancer, glioblastoma. This review will focus on the molecular genetic mechanisms which have recently been identified as being important for neural stem cell self-renewal in brain cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Sustained GRK2-dependent CREB activation is essential for α2-adrenergic receptor-induced PC12 neuronal differentiation

George Karkoulias, Katie A. McCrink, Jennifer Maning, Celina M. Pollard, Victoria L. Desimine, Nicholas Patsouras, Miltiades Psallidopoulos, Stavros Taraviras, Anastasios Lymperopoulos, Christodoulos Flordellis

CELLULAR SIGNALLING (2020)

Review Medical Laboratory Technology

Extracellular vesicles and their role in glioblastoma

Clarissa A. Whitehead, Andrew H. Kaye, Katharine J. Drummond, Samuel S. Widodo, Theo Mantamadiotis, Laura J. Vella, Stanley S. Stylli

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)

Review Immunology

The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer

Alexander James Sedgwick, Nazanin Ghazanfari, Patrick Constantinescu, Theo Mantamadiotis, Alexander David Barrow

FRONTIERS IN IMMUNOLOGY (2020)

Article Oncology

Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs

Marija Dinevska, Natalia Gazibegovic, Andrew P. Morokoff, Andrew H. Kaye, Katharine J. Drummond, Theo Mantamadiotis, Stanley S. Stylli

CANCERS (2020)

Review Oncology

Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment

Samuel S. Widodo, Ryan A. Hutchinson, Yitong Fang, Stefano Mangiola, Paul J. Neeson, Phillip K. Darcy, Alexander D. Barrow, Christopher M. Hovens, Marija Dinevska, Stanley S. Stylli, Theo Mantamadiotis

Summary: Recent developments in cancer immunotherapy offer hope for cancer patients, but difficult to treat cancers such as malignant brain cancer still present challenges, with immune cells in the tumor microenvironment playing a crucial role in regulating tumor immune suppression.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Oncology

IL-10 in glioma

Samuel S. Widodo, Marija Dinevska, Liam M. Furst, Stanley S. Stylli, Theo Mantamadiotis

Summary: The prognosis for patients with GBM is very poor despite current standard treatments. The immunosuppressive tumour microenvironment hinders the development of effective immunotherapies for GBM, and understanding the role of IL-10 in GBM is crucial for improving immunotherapy.

BRITISH JOURNAL OF CANCER (2021)

Review Oncology

The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma

Michael O'Rawe, Ethan J. Kilmister, Theo Mantamadiotis, Andrew H. Kaye, Swee T. Tan, Agadha C. Wickremesekera

Summary: Glioblastoma (GB) is an aggressive brain tumor with poor prognosis despite extensive research. The renin-angiotensin system (RAS) plays a critical role in influencing cancer stem cells and tumor microenvironment in GB. Targeting RAS with existing medications presents a potential new therapeutic strategy for GB treatment.

CANCERS (2021)

Article Cell Biology

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Dylan Jones, Clarissa A. Whitehead, Marija Dinevska, Samuel S. Widodo, Liam M. Furst, Andrew P. Morokoff, Andrew H. Kaye, Katharine J. Drummond, Theo Mantamadiotis, Stanley S. Stylli

Summary: Glioblastoma is a highly invasive and destructive brain tumor, and current standard treatments often fail to effectively eliminate it. In this study, we investigate the effects of several FDA-approved drugs on the invasion and viability of GBM cells. We found that these drugs can reduce cell invasion and viability, suggesting their potential as therapeutic options for GBM.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)

Article Oncology

Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization

Marija Dinevska, Samuel S. Widodo, Liam Furst, Lucero Cuzcano, Yitong Fang, Stefano Mangiola, Paul J. Neeson, Phillip K. Darcy, Robert G. Ramsay, Ryan Hutchinson, Fabienne MacKay, Michael Christie, Stanley S. Stylli, Theo Mantamadiotis

Summary: Tumor microenvironment in malignant astrocytoma undergoes changes in cell composition, cell signaling activation, and extracellular matrix deposition during disease progression. Targeting the extracellular matrix and cell signaling activation will be critical in designing personalized therapy.

CELLULAR ONCOLOGY (2023)

Review Oncology

Advances in CAR T cell immunotherapy for paediatric brain tumours

Padmashree Rao, Liam Furst, Deborah Meyran, Chelsea Mayoh, Paul J. Neeson, Rachael Terry, Dong-Anh Khuong-Quang, Theo Mantamadiotis, Paul G. Ekert

Summary: Pediatric brain tumors are the most common solid tumor in children, and current treatments include surgery, chemotherapy, and radiotherapy. Immunotherapy, especially CAR T cell therapy, may provide new avenues for improved outcomes.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression

Sarah A. Cain, Bernard Pope, Stefano Mangiola, Theo Mantamadiotis, Katharine J. Drummond

Summary: This study aimed to identify somatic mutations and copy number alterations associated with grade progression in meningiomas. Through targeted next-generation sequencing, mutations and CNAs associated with different grade progression were found. NF2 mutations played an important role in grade progression.

BMC CANCER (2023)

Article Oncology

Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner

Clarissa A. Whitehead, Haoyun Fang, Huaqi Su, Andrew P. Morokoff, Andrew H. Kaye, Eric Hanssen, Cameron J. Nowell, Katharine J. Drummond, David W. Greening, Laura J. Vella, Theo Mantamadiotis, Stanley S. Stylli

Summary: In this study, it was found that glioblastoma cells promote invadopodia activity by secreting small extracellular vesicles (sEVs) containing matrix metalloproteinase MMP-2. Additionally, the invasiveness of cells and sEV secretion were increased after radiotherapy/temozolomide treatment. These findings reveal a relationship between sEVs and invadopodia, providing important insights into the functional capacity of sEVs in promoting glioblastoma cell invasion.

CELLULAR ONCOLOGY (2023)

Article Developmental Biology

γH2AX in mouse embryonic stem cells: Distribution during differentiation and following γ-irradiation

Tom C. Karagiannis, Christian Orlowski, Katherine Ververis, Eleni Pitsillou, Gulcan Sarila, Samuel T. Keating, Laura J. Foong, Stefanie Fabris, Christina Ngo-Nguyen, Neha Malik, Jun Okabe, Andrew Hung, Theo Mantamadiotis, Assam El-Osta

Summary: This study investigates the role of phosphorylated histone H2AX (gamma H2AX) as a marker of DNA double-strand breaks (DSBs) and its implication in stem cell differentiation. The research establishes a mouse embryonic stem cell (mESC) differentiation model and examines the dynamics of gamma H2AX foci during the process. The findings reveal that gamma H2AX serves as a versatile marker of DSBs and may have a role as a biomarker in stem cell differentiation.

CELLS & DEVELOPMENT (2024)

Review Biochemistry & Molecular Biology

The renin-angiotensin system in central nervous system tumors and degenerative diseases

Simon Haron, Ethan J. Kilmister, Paul F. Davis, Stanley S. Stylli, Theo Mantamadiotis, Andrew H. Kaye, Sean R. Hall, Swee T. Tan, Agadha C. Wickremesekera

Summary: The Renin-Angiotensin System (RAS) plays a crucial role in both CNS tumors and degenerative diseases by regulating various signaling pathways that affect cellular functions and the development of diseases.

FRONTIERS IN BIOSCIENCE-LANDMARK (2021)

Article Biochemical Research Methods

In vivo imaging of DNA-bound minichromosome maintenance complex in embryonic mouse cortex

Maria Mougkogianni, Argyro Kalogeropoulou, Nickolaos Nikiforos Giakoumakis, Zoi Lygerou, Stavros Taraviras

Summary: Recruitment of the MCM complex on DNA replication origins is critical for faithful genome duplication, with aberrant licensing linked to cancer and neurodevelopmental diseases. An optimized approach for qualitative and quantitative analysis of DNA-bound MCMs in the developing mouse cortex has been developed, offering innovative insights into in vivo research on origin licensing.

STAR PROTOCOLS (2021)

No Data Available